Collaborative Drug Discovery is integrating Eli Lilly’s TuneLab predictive models directly into the CDD Vault platform to provide biotech firms with proprietary ADMET research data. This partnership allows developers and data scientists to deploy elite pharmaceutical models within existing computational workflows without managing separate infrastructure. Expect broader industry adoption of these collaborative AI modules as web-based platforms increasingly democratize access to high-value proprietary training sets for drug discovery.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
0
Ali NematiWritten by Ali
